source
- SystImmune/BMS and Hengrui showcase ADC data for EGFR-mutant lung cancer at ESMOAt the European Society for Medical Oncology (ESMO) meeting in Madrid, Li Zhang of Sun Yat-sen University Cancer Center presented early data from the HERON‑Lung01 study, highlighting an antibody‑dr…
- Bristol Myers Squibb partners with Institute for Healthcare Improvement to increase cancer trial participationBristol Myers Squibb has entered a three-year collaboration with the Institute for Healthcare Improvement called the Cancer Collective Action Collaborative. The program will bring together 24 team…